Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations

A Twist Bioscience executive sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• Paula Green, SVP of Human Resources at Twist Bioscience, sold 860 shares of common stock on December 6, 2024.
• The sale was executed at a price of $52.704 per share.
• The total value of the shares sold was $13,3715.
• The sale was mandated by the company's equity incentive plan to cover tax withholding obligations associated with the vesting of restricted stock units.
• These transactions are not discretionary trades by the executive but rather a 'sell to cover' transaction.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This type of transaction is common for executives who receive stock-based compensation, as they often need to sell shares to cover the associated tax liabilities.

Comparison to Industry Standards

• Many companies use 'sell to cover' mechanisms as part of their equity compensation plans.
• This type of transaction is a standard practice across the industry for executives receiving stock-based compensation.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.

Key Dates

Keywords

Twist Bioscience, stock sale, executive, tax withholding, restricted stock units, equity incentive plan